Dublin, OH (April 2, 2014) – Biosortia is working with renowned drug discovery researchers at The Ohio State University, University of California Santa Cruz, Ole Miss, and Purdue University. Led by Chief Science Officer, Dr. Guy Carter, each research collaboration is strategically focused to complement Biosortia’s objective in providing Big Pharma with unique and highly portent new chemistry.

###

About Biosortia Pharmaceuticals – Biosortia Pharmaceuticals is a division of Algaeventure Systems (AVS). Biosortia has a proven and unique ability to obtain unculturable aquatic microorganism consortia from the natural environment in unprecedented quantities that allows its research team to perform a direct study of vast quantities of new natural products. Biosortia is actively engaging drug research and development organizations to explore the vast opportunity of unculturable microorganisms for potential therapeutic agents, and other novel compounds of value in biotechnology fields.